|
|
| Line 1: |
Line 1: |
| {{CMG}}
| | #REDIRECT [[Amiodarone#Adult Indications and Dosage]] |
| | |
| Because of its life-threatening side effects and the substantial management difficulties associated with its use Amiodarone is indicated only for the treatment of the following documented, life-threatening recurrent ventricular arrhythmias when these have not responded to documented adequate doses of other available antiarrhythmics or when alternative agents could not be tolerated.
| |
| | |
| # Recurrent [[ventricular fibrillation]]. | |
| # Recurrent hemodynamically [[unstable ventricular tachycardia]]. | |
| | |
| As is the case for other antiarrhythmic agents, there is no evidence from controlled trials that the use of Amiodarone HCl tablets favorably affects survival.
| |
| | |
| Amiodarone HCl tablets should be used only by physicians familiar with and with access to (directly or through referral) the use of all available modalities for treating [[recurrent life-threatening ventricular arrhythmias]], and who have access to appropriate monitoring facilities, including in-hospital and ambulatory continuous electrocardiographic monitoring and electrophysiologic techniques.
| |
| | |
| Because of the life-threatening nature of the [[arrhythmia]]s treated, potential interactions with prior therapy, and potential exacerbation of the arrhythmia, initiation of therapy with Amiodarone should be carried out in the hospital.
| |
| | |
| | |
| {{FDA}}
| |
| | |
| | |
| [[Category:Drugs]]
| |